Debiopharm

13/01/2026

Advancing the fight against “Super Gonorrhea” 🦠

We are thrilled to announce a landmark collaboration and license agreement with the Global Antibiotic R&D Partnership (GARDP) to develop Debio1453, a first-in-class antibiotic targeting 𝘕𝘦𝘪𝘴𝘴𝘦𝘳𝘪𝘢 𝘨𝘰𝘯𝘰𝘳𝘳𝘩𝘰𝘦𝘢𝘦, a bacteria that has developed resistance against nearly every antibiotic ever used to treat it.

💡 With 82M new cases of gonorrhea each year and rising drug resistance, this partnership is building on top of recent advances of new treatments developed to keep gonorrhea treatable for future generations.

Read the PR to learn more
https://www.debiopharm.com/drug-development/press-releases/gardp-and-debiopharm-partner-to-advance-development-of-novel-gonorrhea-drug/

24/11/2025

No man should have to walk their prostate cancer journey alone.🎗️
As we enter the last week of , today we want to shine a light on all the caregivers, family members, and friends who stand by patients every day. Movember reminds us that men’s health is a shared responsibility, and strong support networks help patients feel empowered and less isolated. 🤝

💡 Looking for resources to guide you or someone you care about? 👇
https://www.oncolifestyle.com/

20/11/2025

💡 Did you know that prostate cancer often develops quietly, without perceptible early symptoms?
That’s why talking about men’s health and why getting checked matters. Early diagnosis can make treatment simpler and outcomes better. is about starting these conversations and encouraging action. Let’s make men’s health visible.🎗️

👇 Discover articles to support you on your cancer journey
https://www.oncolifestyle.com/

06/11/2025

🦠 Antimicrobial resistance is the silent storm gathering strength. It is one of the top ten global health threats the world can no longer afford to ignore.

At Debiopharm, we’re working to change the forecast. By advancing truly novel antibiotics that meet World Health Organization (WHO)’s highest standards of innovation, we’re helping protect patients and preserve the future of effective treatment.

👇 Learn more about our commitment agains AMR
https://www.debiopharm.com/our-expertise/antibiotics/

Reference: Threat of AMR - Global AMR R&D Hub [Internet]. [cited 2025 Oct 29].

05/11/2025

It’s , so let’s start conversations and break the silence around men’s health issues that are still too often avoided, like prostate cancer.

💡Prostate cancer is still one of the most common cancers in men, yet it often goes undetected until it’s quite advanced. Movember reminds us that awareness and early detection can make all the difference.

Whether you grow a moustache to get the conversation going, or repost on social media, every gesture helps break the stigma and start meaningful discussions. Let’s make men’s health a priority this month. 🎗️

👉 Stay connected this month as we share more about risk factors, early detection, and the essential role of support.

20/11/2024

Did you struggle with performing physiotherapy exercises properly, too?
According to Colin Schmidt, creator of MYPHISIO, this might be due to a lack of motivation or clear guidance when completing such exercises. To boost patient compliance and prevent the worsening of motor functions, Colin and Wavemind Sàrl developed the MYPHISIO digital app. This innovative tool allows physiotherapists to remotely connect with their clients, enabling users to track their progress and stay motivated.

MYPHISIO is one of the finalist innovations from the Patient’s Quality of Life Challenge, organized annually by Debiopharm, La-solution.ch , and Fondation Inartis. Click here or more information on the challenge: https://www.debiopharm.com/awards-grants/challenge-debiopharm-inartis/

Follow Debiopharm and stay tuned for upcoming videos showcasing the contestants' brilliant inventions! 🌟

Debiopharm, La Solution and Foundation Inartis ‘Challenge’ on the theme ‘Quality of Life for Patients undergoing Treatment.’

13/11/2024

Did you know that one out of three patients who have undergone a surgical foot operation isn't satisfied with the results? 🦶
According to Quentin Praz and Spiros Schoinas, creators of PRESSMAP, this may be due to manual examinations leading to incorrect diagnoses. To address this, Quentin and Spiros developed the PRESSMAP diagnostic tool, which measures specific biomechanical parameters of the foot in a reliable, precise, and automated fashion.

PRESSMAP is one of the finalist innovations from the Patient’s Quality of Life Challenge, organized annually by Debiopharm, La-solution.ch , and Fondation Inartis. Click here for more information on the challenge: https://www.debiopharm.com/awards-grants/challenge-debiopharm-inartis/

Follow Debiopharm and stay tuned for upcoming videos showcasing the contestants' brilliant inventions! 🌟

Debiopharm, La Solution and Foundation Inartis ‘Challenge’ on the theme ‘Quality of Life for Patients undergoing Treatment.’

06/11/2024

Did you know that 50% of patients with chronic diseases struggle with treatment compliance? 📈
Christophe LELONG, founder of Vulgaroo, points out that a major cause is often the lack of clarity in medical instructions. To help address this, Christophe shows how the Vulgaroo platform can simplify medical reports, making them easier for patients to understand.

Vulgaroo is one of the finalist innovations from the Patient’s Quality of Life Challenge, organized annually by Debiopharm, La-solution.ch , and Fondation Inartis. Click here for more information on the challenge: https://lnkd.in/dYxDgkD

Follow Debiopharm and stay tuned for upcoming videos showcasing the contestants' brilliant inventions! 🌟



https://www.youtube.com/watch?v=CVEcHK2ytWw

Did you know that 50% of patients with chronic diseases struggle with treatment compliance? 📈Christophe LELONG, founder of Vulgaroo, points out that a major...

05/11/2024

Ready to embark on an unprecedented artistic journey? 🎭
The mythical character Prometheus, best known for defying the Olympian gods by stealing fire and giving it to humanity, will now be reimagined through an oncology lens by Centro Amazzone, a breast cancer association founded by women, for women. The performances will take place from November 14th to 15th in Palermo, Sicily, and we are proud to sponsor both the theatrical productions and the discussions surrounding cancer prevention and treatment.

Follow Debiopharm to stay on top of our latest updates!

29/10/2024

Did you know that breast cancer patients are at higher risk of anxiety, depression, and early death in comparison to the general population? The importance of mental health challenges is undeniable, and the Centro Amazzone, a renowned Italian patient support group, recognizes the need. Volunteers like Rosaria have dedicated themselves to providing recurrent mental health check-ups, and she would like to do a quick exercise with you right now. What would your response be?

If you enjoyed this interview, consider following Debiopharm for more patient-centric content!

We believe that creative solutions like Centro Amazzone are offering women with breast cancer a better quality of life. Learn more about how we seek to ease patient disease burden here: https://lnkd.in/eZAttCq8

Did you know that breast cancer patients are at higher risk of anxiety, depression, and early death in comparison to the general population? The importance o...

25/10/2024

Navigating life with breast cancer is often compared to enduring a period of crisis - a crisis of the body, but also a shift in how others perceive you. In this interview, Lina Prosa and her fellow colleagues from the Centro Amazzone, a renowned Italian patient support group, discuss how theater and Greek mythology serve as cathartic metaphors for the battle against cancer.

If you enjoyed this interview, consider following Debiopharm and stay tuned for the next one!

We believe that creative solutions like Centro Amazzone are offering women with breast cancer a better quality of life. Learn more about how we seek to ease patient disease burden here:
https://lnkd.in/eZAttCq8

Navigating life with breast cancer is often compared to enduring a period of crisis - a crisis of the body, but also a shift in how others perceive you. In t...

18/10/2024

At the beginning of October, we announced receiving a visit from the famous Italian breast cancer support group, the Centro Amazzone. Today, we share the first of three interviews, in which Anna Barbera, one of the two founders, narrates how, from a dramatic event like breast cancer, an earth-shattering initiative can be born.
If you liked this interview, consider following Debiopharm and stay tuned for the next two interviews!

We believe that creative solutions like Centro Amazzone are offering women with breast cancer a better quality of life. Learn more about how we seek to ease patient disease burden here: https://lnkd.in/eZAttCq8

At the beginning of October, we received a visit from the famous Italian breast cancer support group, the Centro Amazzone. Today, we share the first of three...